Regulation of angiotensin II receptors and extracellular matrix turnover in human retinal pigment epithelium: Role of angiotensin II

American Journal of Physiology - Cell Physiology

Volumn 295, Issue 6, 2008, Pages

  Striker, Gary E ^b   Praddaude, Francoiçe ^c   Alcazar, Oscar ^a   Cousins, Scott W ^d   Marin Castaño, Maria E ^a,e  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITÉ DE TOULOUSE   (France)

^d DUKE UNIVERSITY EYE CENTER   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Bruch's membrane; Calcium; Hypertension

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; CANDESARTAN; COLLAGEN TYPE 4; GELATINASE A; MATRIX METALLOPROTEINASE 14; MESSENGER RNA;

ARTICLE; BRUCH MEMBRANE; CALCIUM CELL LEVEL; COLLAGEN DEGRADATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HYPERTENSION; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR;

ANGIOTENSIN II; BLOTTING, WESTERN; CELL LINE; COLLAGEN TYPE IV; EXTRACELLULAR MATRIX; HUMANS; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; RECEPTORS, ANGIOTENSIN; RETINAL PIGMENT EPITHELIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 57349092212     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00092.2008     Document Type: Article

References (81)

1. Abdelsalam A, Del Priore L, Zarbin MA. Drusen in age-related macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression. Surv Ophthalmol 44: 1-29, 1999.
2. Ahir A, Guo L, Hussain AA, Marshall J. Expression of metalloproteinases from human retinal pigment epithelial cells and their effects on the hydraulic conductivity of Bruch's membrane. Invest Ophthalmol Vis Sci 43: 458-465, 2002.
3. Arenas IA, Xu Y, Lopez-Jaramillo P, Davidge ST. Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-α. Am J Physiol Cell Physiol 286: C779-C7784, 2004.
4. Atkison SJ, Petterson ML, Butler MJ, Murphy G. Membrane type 1 matrix metalloproteinase and gelatinase A synergistically degrade type I collagen in a cell model. FEBS Lett 491: 222-226, 2001.
5. Aumailley M, Gayraud B. Structure and biological activity of the extracellular matrix. J Mol Med 76: 253-265, 1998.
6. Baramova EN, Bajou K, Remacle A, L'Hoir C, Krell HW, Weidle UH, Noel A, Foidart JM. Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation. FEBS Lett 405: 157-162, 1997.
7. Bascands JL, Pecher C, Rouaud S, Emond C, Tack I, Bastie MJ, Burch R, Regoli D, Girolami JP. Evidence for existence of two distinct bradykinin receptors on rat mesangial cells. Am J Physiol Renal Fluid Electrolyte Physiol 264: F548-F556, 1993.
8. Berka JL, Stubbs AJ, Wang DZM, Dinocolantonio R, Alcorn D, Campbell DJ, Skinner SL. Renin-containing Muller cells of the retina display endocrine features. Invest Ophthalmol Vis Sci 36: 1450-1458, 1995.
9. Burns RP, Feeney-Burns L. Clinico-morphologic correlations of drusen of Bruch's membrane. Trans Am Ophthalmol Soc 78: 206-225, 1980.
10. Brandt CR, Pumfery AM, Micales B, Bindley CD, Lyons GE, Sramek SJ, Wallow IH. Renin mRNA is synthesized locally in rat ocular tissues. Curr Eye Res 13: 755-763, 1994.
11. Campochiaro PA, Jerdon JA, Glaser BM. The extracellular matrix of human retinal pigment epithelial cells in vivo and its synthesis in vitro. Invest Ophthalmol Vis Sci 27: 1615-1621, 1986.
12. Castoldi G, Di Gioia CR, Pieruzzi F, d'Orlando C, Van de Greef WM, Busca G, Sperti G, Stella A. ANG II increases TIMP-1 expression in rat aortic smooth muscle cells in vivo. Am J Physiol Heart Circ Physiol 284: H635-H643, 2003.
13. Chen CP, Yang YC, Su TH, Chen CY, Aplin JD. Hypoxia and transforming growth factor-beta 1 act independently to increase extracellular matrix production by placental fibroblasts. J Clin Endocrinol Metab 90: 1083-1090, 2005.
14. Chen S, Lee JS, Iglesias-de la Cruz MC, Wang A, Izquierdo-Lahuerta A, Gandhi NK, Danesh FR, Wolf G, Ziyandeh F. Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGF-b and VEGF signaling: implications for diabetic glomerulopathy. Nephrol Dial Transplant 20: 1320-1328, 2005.
15. Cui XL, Ding Y, Alexander LD, Bao C, Al-Khalili OK, Simonson M, Eaton DC, Douglas JG. Oxidative signaling in renal epithelium: critical role of cytosolic phospholipase A2 and p38(SAPK). Free Radic Biol Med 41: 190-192, 2006.
16. Danser AH, Derkx FH, Admiraal PJ, Deinum J, de Jong PT, Schalekamp MA. Angiotensin levels in the eye. Invest Ophthalmol Vis Sci 35: 1008-1018, 1994.
17. De Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International Union of Pharmacology. XXIII. The angiotensin II. Pharmacol Rev 52: 415-472, 2000.
18. De Jong PT. Age-related macular degeneration. N Engl J Med 355: 1474-1485, 2006.
19. Deryugina EI, Bourdon MA, Reisfeld RA, Strongin A. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2. Cancer Res 58: 3743-3750, 1989.
20. Eagleton MJ, Ballard N, Lynch E, Srivastava SD, Upchurch GR Jr, Stanley JC. Early increased MT1-MMP expression and late MMP-2 and MMP-9 activity during angiotensin II induced aneurysm formation. J Surg Res 135: 345-51, 2006.
21. 2+ signaling in afferent arterioles. Am J Physiol Renal Physiol 289: F1012-F1019, 2005.
22. Ferrari-Dileo G, Davis EB, Anderson DR. Angiotensin II binding receptors in retinal and optic nerve head blood vessels. An autoradiographic approach. Invest Ophthalmol Vis Sci 32: 21-26, 1991.
23. Fine SL, Berger JW, Maguire MG, Ho AC. Age-related macular degeneration. N Engl J Med 342: 483-492, 2000.
24. Flamant M, Placier S, Dubroca C, Esposito B, Lopes I, Chatziantoniou C, Tedgui A, Dussaule JC, Lehoux S. Role of matrix metalloproteinases in early hypertensive vascular remodeling. Hypertension 50: 213-218, 2007.
25. Green WR. Histopathology of age-related macular degeneration. Mol Vis 5: 27, 1999.
26. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-345, 1985.
27. Han SY, Jee YH, Han KH, Kang YS, Kim HK, Han JY, Kim YS, Cha DR. An imbalance between MMP-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early nephropathy. Nephrol Dial Transplant 21: 2406-2416, 2006.
28. 2+ signaling in BHK cells expressing cloned human glucagons receptors. Am J Physiol Cell Physiol 274: C1552-C1556, 1998.
29. Hayreh SS, Servais GE, Virdis PS. Macular lesions in malignant arterial hypertension. Ophthalmology 198: 230-246, 1989.
30. i responses to ANG II. Am J Physiol Renal Physiol 273: F84-F96, 1997.
31. Hernandez-Barrantes S, Toth M, Bernardo MM, Yurkov M, Gervasi DC, Raz Y, Sang QA, Fridman R. Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. J Biol Chem 275: 12080 -12089, 2000.
32. 2+-sensitive PKC-dependent tyrosine kinase pathway. Acta Physiol Scand 168: 301-309, 2000.
33. Huang W, Yu LF, Zhong J, Qizo MM, Jiang FX, Du F, Tian XL, Wu YL. Angiotensin II type 1 receptor expression in human gastric cancer and induces MMP2 and MMP9 expression in MKN-28 cells. Dig Dis Sci 53: 163-168, 2008.
34. Hyman L, Schachat AP, He Q, Leske MC. Hypertension, cardiovascular disease, and age-related macular degeneration. Arch Ophthalmol 118: 351-358, 2000.
35. Ishibashi T, Patterson R, Ohnishi Y, Inomata H, Ryan SJ. Formation of drusen in the human eye. Am J Ophthalmol 101: 342-353, 1986.
36. Jacot TA, Striker GE, Stetler-Stevenson M, Striker LJ. Mesangial cells from transgenic mice with progressive glomerulosclerosis exhibit stable, phenotypic changes including undetectable MMP-9 and increased type IV collagen. Lab Invest 75: 791-799, 1996.
37. Jonas JB, Hayreh SS, Martus P. Influence of arterial hypertension and diet-induced atherosclerosis on macular drusen. Graefes Arch Clin Exp Ophthalmol 241: 125-134, 2003.
38. Kigasawa K, Ishikawa H, Obazawa H, Minamoto T, Nagai Y, Tanaka Y. Collagen production by cultured human retinal pigment epithelial cells. Tokai J Exp Clin Med 23: 147-151, 1998.
39. Klein R, Klein BE, Tomany SC, Cruickshanks KJ. The association of cardiovascular disease with the long-term incidence of age-related maculopathy. Ophthalmology 110: 1273-1280, 2003.
40. Klein R, Peto T, Bird A, Vannewkirk MR. The epidemiology of age-related macular degeneration. Am J Ophthalmol 137: 486-495, 2004.
41. Kohler KWST, Jurlikes B, Guenther E, Zrenner E. Angiotensin II in the rabbit retina. Vis Neurosci 14: 63-71, 1997.
42. Kugler A. Matrix metalloproteinases and their inhibitors. Anticancer Res 19: 1589-1592, 1999.
43. Lee M, Bohm M, Paul M, Ganden D. Tissue renin-angiotensin systems: their role in the cardiovascular disease. Circulation 101: 1362-1365, 2000.
44. Lijnen P, Papparella I, Petrov V, Semplicini A, Fagard R. Angiotensin II-stimulated collagen production in cardiac fibroblasts is mediated by reactive oxygen species. J Hypertens 24: 757-766, 2006.
45. Marin-Castaño ME, Elliot SJ, Potier M, Karl M, Striker LJ, Striker GE, Csaky KG, Cousins SW. Regulation of estrogen receptors and MMP-2 expression by estrogens in human retinal pigment epithelium. Invest Ophthalmol Vis Sci 44: 50-59, 2003.
46. Marin-Castaño ME, Csaky KG, Cousins SW. Nonlethal oxidant injury to human retinal pigment epithelium cells causes cell membrane blebbing but decreased MMP-2 activity. Invest Ophthalmol Vis Sci 46: 3331-3340, 2005.
47. Marin-Castaño ME, Striker GE, Alcazar O, Catanuto P, Espinosa-Heidmann DG, Cousins SW. Repetitive nonlethal oxidant injury to retinal pigment epithelium decreased extracellular matrix turnover in vitro and induced sub-RPE deposits in vivo. Invest Ophthalmol Vis Sci 47: 4098-4112, 2006.
48. Marmor MF. Structure and function of the retinal pigment epithelium. Int Ophthalmol Clin 15: 115-130, 1975.
49. McConnell V, Silvestri G. Age-related macular degeneration. Ulster Med J 74: 82-92, 2005.
50. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292: C82-C97, 2007.
51. Mukoyama M. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem 268: 24539-24542, 1993.
52. Murphy TJ, Wayne Alexander R, Griendling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 351: 233-236, 1991.
53. Newsome DA, Pfeffer BA, Hewitt AT, Robey PG, Hassell JR. Detection of extracellular matrix molecules synthesized in vitro by monkey and human retinal pigment epithelium: influence of donor and multiple passages. Exp Eye Res 46: 305-321, 1988.
54. Nowak JZ. Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep 58: 353-363, 2006.
55. Obayashi K, Akamatsu H, Okano Y, Matsunaga K, Masaki H. Exogenous nitric oxide enhances the synthesis of type I collagen and heat shock protein 47 by normal human dermal fibroblasts. J Dermatol Sci 41: 121-126, 2006.
56. Otani A, Takagi H, Suzuma K, Honda Y. Angiotensin II potentiates endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells. Circ Res 82: 619-628, 1998.
57. 2-chain type IV collagen mRNAs in adult mouse glomeruli: competitive PCR. Am J Physiol Renal Fluid Electrolyte Physiol 263: F951-F957, 1992.
58. Ruiz-Ortega M, Ruperez M, Esteban V, Egido J. Molecular mechanisms of angiotensin II-induced vascular injury. Curr Hypertens Rep 5: 73-79, 2003.
59. Saghizadeh M, Kramerov AA, Tajbakhsh J, Aoki AM, Wang C, Chai NN, Ljubimova JY, Sasaki T, Sosne G, Carlson MR, Nelson SF, Ljubimov AV. Proteinase and growth factor alterations revealed by gene microarray analysis of human diabetic corneas. Invest Ophthalmol Vis Sci 46: 3604-3615, 2005.
60. Sánchez-López E, Rodriguez-Vita J, Cartier C, Rupérez M, Esteban V, Carvajal G, Rodrígues-Díez R, Plaza JJ, Egido J, Ruiz-Ortega M. Inhibitory effect of interleukin-1β on angiotensin II-induced connective tissue growth factor and type IV collagen production in cultured mesangial cells. Am J Physiol Renal Physiol 294: F149-F160, 2008.
61. Sarks S, Cherepanoff S, Killingsworth M, Sarks J. Relationship of basal laminar deposit and membranous debris to the clinical presentation of early age-related macular degeneration. Invest Ophthalmol Vis Sci 48: 968-977, 2007.
62. Sarlos S, Rizkalla B, Moravski CJ, Cao Z, Cooper ME, Wilkinson-Berka JL. Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin. Am J Pathol 163: 879-887, 2003.
63. Sato T, Niwa M, Himeno A, Tsutumi K, Amemiya T. Quantitative receptor autoradiographic analysis for angiotensin II receptors in bovine retinal microvessels: quantitation with radioluminography. Cell Mol Neurobiol 13: 233-245, 1993.
64. Satofuka S, Ichihara A, Nagai N, Yamashiro K, Koto T, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota K, Suzuki F, Oike Y, Ishida S. Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin. Invest Ophthalmol Vis Sci 47: 2686-2692, 2006.
65. Savaskan E, Löffler KU, Meie F, Müller-Spahn F, Flammer J, Meyer P. Immunohistochemical localization of angiotensin-converting enzyme, angiotensin II and AT1 receptor in human ocular tissues. Ophthalmic Res 36: 312-320, 2004.
66. Seeger H, Lippert C, Wallwiener D, Mueck AO. Valsartan and candesartan can inhibit deteriorating effects of angiotensin II on coronary endothelial function. J Renin Angiotensin Aldosterone Syst 2: 141-143, 2001.
67. Senanayake P, Drazba J, Shadrach K, Milsted A, Rungger-Bandle E, Nishiyama K, Miura S, Kamik S, Sears JE, Hollyfield JG. Angiotensin II and its receptor subtypes in the human retina. Invest Ophthalmol Vis Sci 48: 3301-3311, 2007.
68. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270: 5331-5338, 1995.
69. Taylor WR. Hypertensive vascular disease and inflammation: mechanical and humoral mechanisms. Curr Hypertens Rep 1: 96-101, 1999.
70. Uchiyama-Tanaka Y, Matsubara H, Nozawa Y, Murasawa S, Mori Y, Kosaki A, Maruyama K, Masaki H, Shibasaki Y, Fujiyama S, Nose A, Iba O, Hasagawa T, Tateishi E, Higashiyama S, Iwasaka I. Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells. Kidney Int 60: 2153-2163, 2001.
71. Wagner J, Danser AHJ, Derkx FHM, de Jong TV, Paul M, Mullins JP, Schalekamp MA, Ganten D. Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system. Br J Ophthalmol 80: 159-163, 1996.
72. 2+ channel expression in endothelial cells. Biochem Biophys Res Commun 347: 394-400, 2006.
73. Wang M, Zhang J, Spinetti G, Jiang LQ, Monticone R, Zhao D, Cheng L, Krawczyk M, Talan M, Pintu SG, Lakatta EG. Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats. Am J Pathol 167: 1429-1442, 2005.
74. Weiss RH, Ramirez A. TGF-beta- and angiotensin-II-induced mesangial matrix protein secretion is mediated by protein kinase C. Nephrol Dial Transplant 13: 2804-2813, 1998.
75. Wheeler-Schilling TH, Kohler K, Sautter M, Guenther E. Angiotensin II receptor subtypes gene expression and cellular localization in the retina and non-neuronal ocular tissues of the rat. Eur J Neurosci 11: 3387-3394, 1999.
76. Wolf G. Angiotensin II and tubular development. Nephrol Dial Transplant 17: 48-51, 2002. Review.
77. Wolf G, Ziyadeh NF. Renal tubular hypertrophy induced by angiotensin II. Semin Nephrol 17: 448-454, 1997.
78. Young RW. Pathophysiology of age-related macular degeneration. Surv Ophthalmol 31: 291-306, 1987.
79. Zhu ZR, Goodnight R, Nishimura T, Sorgente N, Ogden TE, Ryan SJ. Experimental changes resembling the pathology of drusen in Bruch's membrane in the rabbit. Curr Eye Res 7: 581-592, 1998.
80. Zhuge Y, Xu J. Rac1 mediates type I collagen-dependent MMP-2 activation: role in cell invasion across collagen barrier. J Biol Chem 276: 16248-16256, 2001.
81. 1 receptors in proximal tubule cells. Am J Physiol Renal Physiol 290: F1382-F1390, 2006.